Dmitry Balyasny’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Dmitry Balyasny’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-123,881	Closed	-$686K	–	2555
2023 Q2	$686K	Buy	+123,881	New	+$679K	﹤0.01%	1761
2023 Q1	–	Sell	-490,214	Closed	-$3.43M	–	2973
2022 Q4	$3.43M	Buy	+490,214	New	+$5.04M	0.01%	1191

Other funds holding MSOS

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

YCM

Yost Capital Management Houston, Texas $68.9M AUM 18.32% 1-Year Est. Return

LAM

LifePro Asset Management San Diego, California $163M AUM 25.54% 1-Year Est. Return

Dmitry Balyasny's MSOS Position: Q3 2023 in Review

Dmitry Balyasny sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2023, closing a stake of 123,881 shares — an estimated $686K sold.

Dmitry Balyasny first reported a position in MSOS in Q4 2022 and held it in 2 quarters. The position peaked at $3.43M in Q4 2022. 162 funds tracked by Wall St. Rank hold MSOS as of Q3 2023.

Dmitry Balyasny reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2023 after selling out during the quarter.
Dmitry Balyasny sold 123,881 AdvisorShares Pure US Cannabis ETF shares in Q3 2023, an estimated $686K.
Dmitry Balyasny first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and held it in 2 quarters.
Dmitry Balyasny's AdvisorShares Pure US Cannabis ETF position peaked at $3.43M in Q4 2022.
162 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.